- Global Pharma News & Resources

DNA/Gene Microarray Market Exclusivity – Industry will Drive Huge ROI at US$ 7,693.0 Million during 2020 to 2027 | CMI

Traditional solid-phase array and alternative bead array are some of the types of DNA microarray. Major applications of DNA/Gene microarray include, genomics, gene expression, Single Nucleotide Polymorphism (SNP) analysis, and proteomics.

The global DNA/gene microarray market is estimated to account for US$ 3,018.3 Mn in terms of value in 2020 and is expected to reach US$ 7,693.0 Mn by the end of 2027.

Request Sample Copy of the Business Report:

Global DNA/Gene Microarray Market: Drivers

Significant developments in personalized medicines is expected to fuel growth of the global DNA/gene microarray market over the forecast period. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.

Global DNA/Gene Microarray Market: Opportunities 

Increasing investment in DNA sequencing is expected to offer lucrative growth opportunities for players in the market. For instance, in January 2020, Element Biosciences, a biotechnology startup, raised US$ 80 million to develop DNA sequencing platform.

Global DNA/Gene Microarray Market: Restraints

Presence of alternative technologies is expected to hamper growth of the global DNA/gene microarray market. Protein chip and lab-on-chip, glycomic arrays, tissue arrays, and cell arrays are some of the alternatives to DNA/gene microarray.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @

Key Takeaways:

The global DNA/gene microarray market was valued at US$ 2,640.7 Mn in 2019 and is forecast to reach a value of US$ 7,693.0 Mn by 2027 at a CAGR of 12.4% between 2020 and 2027. The market is expected to witness significant growth owing to increasing technological advancement in microarray technology, and increasing demand for genetic testing.

Gene expression and SNP analysis segment held dominant position in the global DNA/gene microarray market in 2019, accounting for 25.6% share in terms of value, followed by oncology and drug development, respectively. Increasing drug development, and demand for personalized medicine is expected to support growth of the segment over the forecast period.

North America held dominant position in the global DNA/gene microarray market in 2019, accounting for 34.1% share in terms of value, followed by Europe and Asia Pacific, respectively. North America has presence of leading manufacturers, and wide number of research institutes which make use of these products. These factors are expected to support growth of the market over the forecast period.

Market Trends

The market is witnessing launch of new genetic tests. For instance, in July 2019, MyHeritage, an online genealogy platform with web, mobile, and software products and services, launched new Health+Ancestry test, a health-related genetic test.

The market is also witnessing increasing adoption of nanoarrays, owing to their various advantages in terms of sensitivity, specificity, speed, portability, throughput, and cost. Nanoarrays find application in drug discovery and disease diagnosis.

View Press Release For More Information @

Global DNA/Gene Microarray Market: Competitive Landscape  

Major players operating in the global DNA/gene microarray market include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc.

Global DNA/Gene Microarray Market: Key Developments  

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in February 2020, Twist Bioscience Corporation launched the Twist Targeted Methylation Sequencing Solution to study methylation pattern changes in a wide range of research fields including cancer

Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in December 2019, Oncology Pharma, Inc. signed a Letter of Intent to acquire at least a 50% stake in Diagnomics, Inc., a private CLIA certified & CAP accredited private molecular Genomics lab and provider of DNA microarrays, Next Generation Sequencing, and real-time PCR solutions


  • By Type
    • oDNA
    • cDNA
  • By Application
    • Genomics
    • Proteomics
    • Agricultural biology
    • Environment
    • Drug R&D
    • Gene expression and SNP analysis
    • Cancer/oncology
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 08-Feb-2021